Development of ibuprofen tablet with polyethylene oxide using fused deposition modeling 3D-printing coupled with hot-melt extrusion

被引:15
|
作者
Chung, Sooyeon [1 ]
Srinivasan, Priyanka [1 ]
Zhang, Peilun [1 ]
Bandari, Suresh [1 ]
Repka, Michael A. [1 ,2 ,3 ]
机构
[1] Univ Mississippi, Sch Pharm, Dept Pharmaceut & Drug Delivery, University, MS 38677 USA
[2] Univ Mississippi, Pii Ctr Pharmaceut Technol, University, MS 38677 USA
[3] Univ Mississippi, Pii Ctr Pharmaceut Technol, Sch Pharm, Dept Pharmaceut & Drug Delivery, University, MS 38677 USA
基金
美国国家卫生研究院;
关键词
Fused deposition modeling 3D-printing; Hot -melt extrusion; Ibuprofen; Rapid release; Polyethylene oxide; DRUG-RELEASE; DISSOLUTION PROFILES; INNOVATIVE APPROACH; 3D; IMMEDIATE; RHEOLOGY;
D O I
10.1016/j.jddst.2022.103716
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ibuprofen is known to plasticize several polymers used in hot-melt extrusion, and it is considered challenging to achieve immediate release for ibuprofen using fused deposition modeling. Therefore, this study aimed to print ibuprofen tablets with a focus on achieving rapid release. Polyethylene oxide (Polyox WSR N80) was used as the main matrix to form the ibuprofen filament, because of its water-soluble properties and ability to manifest suitable mechanical properties, even with high drug loading (40% w/w). Several release modifiers, such as Kollidon VA64, Kollidon 12PF, Kollicoat IR, Kollidon CL, and mannitol, were added separately to the formula-tion, following which their effects on enhancing the drug release rate were investigated. Their effects on the mechanical properties of the filaments have also been assessed in this study. It was demonstrated that adding soluble Kollidon grades, such as Kollidon VA64 and Kollidon 12PF, enhanced the drug release rate. In addition, the tablet design with a high surface-to-mass ratio was beneficial for increasing the drug release rate. However, incorporation of the release modifiers discussed above decreased the flexural modulus of the filament. Addi-tionally, it is important to tailor the printing parameters by considering the properties of the filament, to acquire good quality printlets. The tablet consisting of 30% ibuprofen and 20% Kollidon VA64 at the highest dose used in this study (84 mg) released 80% of the drug, in approximately 90 min. To further increase the release rate and drug dose, other additives, such as viscosity-increasing agents and reinforcing additives, can be explored. This study shows the potential of fabricating ibuprofen tablets with rapid release characteristics using Polyox WSR N80, via fused deposition modeling 3D-printing.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Exploring tablet design options for tailoring drug release and dose via fused deposition modeling (FDM) 3D printing
    Buyukgoz, Guluzar Gorkem
    Soffer, David
    Defendre, Jackenson
    Pizzano, Gia M.
    Dave, Rajesh N.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 591
  • [42] Patient-focused programable release indomethacin tablets prepared via conjugation of hot melt extrusion (HME) and fused depositional modeling (FDM)-3D printing technologies
    Huang, Lianghao
    Yang, Weiwei
    Bu, Yuru
    Yu, Mingchao
    Xu, Minghui
    Guo, Jingjing
    Ni, Wen
    Jia, Yaru
    Zhang, Jiaxiang
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 97
  • [43] Miscibility, phase behavior, and mechanical properties of copovidone/ HPMC ASLF and copovidone/Eudragit EPO polymer blends for hot-melt extrusion and 3D printing applications
    Patel, Gaurang
    Minko, Tamara
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2025, 670
  • [44] Enhancing 3D food printing precision: Development and interaction behavior of soy protein isolate-konjac glucomannan-xanthan gum composite ink based on hot-melt extrusion
    Dai, Hongmin
    Wen, Luming
    Liang, Hongshan
    Li, Bin
    Li, Jing
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 304
  • [45] Preparation, evaluation, and pharmacokinetics in beagle dogs of a taste-masked flunixin meglumine orally disintegrating tablet prepared using hot-melt extrusion technology and D-optimal mixture design
    Xu, Yangfeng
    Yan, Guoqing
    Wen, Xuemei
    Wu, Liqin
    Deng, Ruihan
    Liang, Qiuling
    Zhang, Linjie
    Chen, Hangping
    Feng, Xin
    He, Jiakang
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 168
  • [46] Feasibility of high melting point hydrochlorothiazide processing via cocrystal formation by hot melt extrusion paired fused filament fabrication as a 3D-printed cocrystal tablet
    Nyavanandi, Dinesh
    Mandati, Preethi
    Narala, Sagar
    Alzahrani, Abdullah
    Kolimi, Praveen
    Pradhan, Adwait
    Bandari, Suresh
    Repka, Michael A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 628
  • [47] The development and optimisation of gastro-retentive floating tablets using fused deposition modelling 3D printing
    Oladeji, Sinmisola A.
    Dadou, Suha M.
    Zhao, Min
    Li, Shu
    Jones, David S.
    Andrews, Gavin P.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2022, 74 (10) : 1450 - 1466
  • [48] The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality
    Araujo, Maisa R. P.
    Sa-Barreto, Livia L.
    Gratieri, Tais
    Gelfuso, Guilherme M.
    Cunha-Filho, Marcilio
    PHARMACEUTICS, 2019, 11 (03)
  • [49] Enhancing Patient-Centric Drug Development: Coupling Hot Melt Extrusion with Fused Deposition Modeling and Pressure-Assisted Microsyringe Additive Manufacturing Platforms with Quality by Design
    Nyavanandi, Dinesh
    Mandati, Preethi
    Vidiyala, Nithin
    Parupathi, Prashanth
    Kolimi, Praveen
    Mamidi, Hemanth Kumar
    PHARMACEUTICS, 2025, 17 (01)
  • [50] An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing
    Gultekin, Hazal Ezgi
    Tort, Serdar
    Acarturk, Fusun
    PHARMACEUTICAL RESEARCH, 2019, 36 (09)